Abstract
Hermansky-Pudlak syndrome (HPS) was first described in 1959 by Hermansky and Pudlak. Clinically, HPS is characterized by oculocutaneous albinism, platelet storage pool deficiency, and ceroid tissue accumulation. It is a rare disorder that has been described globally but has the highest frequency in a cluster population in Puerto Rico. HPS patients also have major organ involvement that typically includes pulmonary fibrosis and granulomatous colitis. Rarely have cardiomyopathy and renal dysfunction been described. We report a case of the oldest historical patient with HPS type 6 and the associated gastrointestinal management.
MeSH terms
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Blood Transfusion
-
Enterocolitis / etiology
-
Enterocolitis / therapy
-
Gastrointestinal Agents / therapeutic use
-
Gastrointestinal Diseases / diagnosis
-
Gastrointestinal Diseases / etiology
-
Gastrointestinal Diseases / therapy*
-
Gastrointestinal Hemorrhage / etiology
-
Gastrointestinal Hemorrhage / therapy
-
Hermanski-Pudlak Syndrome / complications*
-
Humans
-
Male
-
Middle Aged
-
Probiotics / therapeutic use
-
Steroids / therapeutic use
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Gastrointestinal Agents
-
Steroids